Sort by
Search results
Heparin testing according to EP/USP/FDA
BIOPHEN Antithrombin LRT (anti-(h)-Xa, Liquid Reagent Technology)
Diagnosis of congenital or acquired antithrombin deficiencies.
BIOPHEN Antithrombin LRT (anti-(h)-Xa, Liquid Reagent Technology)
Diagnosis of congenital or acquired antithrombin deficiencies.
CoaChrom® Prothrombin -> SEE NEW REF. 400001
Assay proposed for the measurement of prothrombin (Factor II) in research applications.
BIOPHEN FVIIa Control Set
BIOPHEN FVIIa Control Set is a set of controls intended for the quality control of activated factor VII (FVIIa) activity measurements, the BIOPHEN FVIIs colorimetric assay with the kit BIOPHEN Factor VIIa (ref. 221312) and the clotting assay with the kit HEMOCLOT Factor VIIa assay (ref. CK092K).
HEMOCLOT Factor VIIa Reagent
Assay proposed for the measurement of factor VIIa activity citrated plasma or purified medium.
BIOPHEN™ Factor XIII
Factor X, CoaChrom®
Assay proposed for the measurement of factor X in research applications.
NAPTT Reagent Kit
Liquid "ready for use", containing synthetic phospholipid blend. This kit is intended for use in the European Pharmacopoeia (EP) method for the detection of activated coagulation factors in therapeutic products. Also, the NAPTT reagent alone can be used in the NAPTT test for detecting contact activation and hypercoagulability (For Research Use Only).
HEMOCLOT VII-X
Vitamin K deficiency. Vitamin K antagonists. Isolated factor VII or X deficiency. Accelerated clotting factor consumption (DIC).